Community-Centered eHealth Smoking Cessation Intervention(CCeSCI)
1 other identifier
interventional
60
1 country
1
Brief Summary
Recent findings regarding why Chinese male smokers are reluctant to quit have offered insight for a possible new solution. Consistent with the Cognitive Dissonance Theory, "smoking rationalization beliefs" are a set of beliefs by smokers to rationalize their smoking behavior and avoid quitting. These beliefs have been well studied by global researchers, and a "smoking rationalization beliefs" scale was recently developed and validated for Chinese male smokers. The six dimensions of these beliefs are: smoking functional beliefs, risk generalization beliefs, social acceptability beliefs, safe smoking beliefs, self-exempting beliefs, and quitting is harmful beliefs. Studies on smoking rationalization in China have primarily been observational. Investigators propose to develop a Community-Centered eHealth Smoking Cessation Intervention (CCeSCI). The trinity of CCeSCI are the triangular unity of "smoking rationalization beliefs" framework, the non-physician community workers, and the eHealth technologies. The latter two were previously proven effective in interventional studies (including three conducted by the PI) but not yet widely used in smoking cessation. With the adoption of smoking rationalization beliefs framework aiming to address the cognitive causes of phycological addition to smoking and supported by the community-based behavioral interventions and the use of eHealth, CCeSCI is designed to overcome previous challenges with the principles of people-centeredness, convenience, and personalization.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Mar 2023
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 15, 2022
CompletedFirst Posted
Study publicly available on registry
August 19, 2022
CompletedStudy Start
First participant enrolled
March 13, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 31, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2023
CompletedFebruary 28, 2024
February 1, 2024
3 months
August 15, 2022
February 25, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Biochemically verified continuous smoking abstinence at 3 month
Investigators will use cotinine to measure the smoking abstinence. Cotinine is a good biomarker for nicotine with a longer half-life (16-18h), and lab test for saliva is highly sensitive, convenient, and cost-effective. measured by cotinine saliva tests (\<10ng•mL-1)
3 month
Secondary Outcomes (10)
Fagerstrom Test For Nicotine Dependence (FTND) Score
Change from baseline to 3-month follow up
Patient Health Questionnaire-9
Change from baseline to 3-month follow up
Self-reported 7-day point smoking status
3-month follow up
Self-reported continuous abstinence at 3 month
3-month follow up
Self-reported average number of cigarettes
Change from baseline to 3-month follow up
- +5 more secondary outcomes
Study Arms (2)
Community-Centered eHealth Smoking Cessation Intervention (CCeSCI) group
EXPERIMENTALThe intervention group will receive Community-Centered eHealth Smoking Cessation Intervention(CCeSCI).
Traditional "smoking is harmful" education group
ACTIVE COMPARATORThe control group to receive the traditional "smoking is harmful" education.
Interventions
We will equip CCeSCI with both core eHealth features and provider-side intervention. Patients assigned to the intervention group will receive a series of online interactive and personalization technologies, including an algorithm-based video curriculum with auto-texting, backstage monitoring system etc. Besides, the patients will also have the face-to-face meetings with community health workers. Provider-side intervention includes training for community workers, WeChat group discussion, and performance-based incentives. The training aims to provide essential skills for community workers so that they can provide face-to-face meetings with smokers during the first 3 months of quitting to prevent or revert relapse in a timely and proactive manner.
In the control group, the participants will receive traditional "smoking is harmful" education video, which is recorded by the clinical physicians.
Eligibility Criteria
You may qualify if:
- Male, current cigarette smokers who are willing to quit
- Citizens who currently reside in Qingpu District, Shanghai, China
- Age 25-64
- Smoking index greater than or equal to 100 (smoking index = average number of cigarettes smoked per day Ă— years of smoking)
- Able to understand mandarin Chinese
- Willing to provide informed consent to participate in the study
You may not qualify if:
- Ever or currently on pharmacologic treatments, including various forms of NRT formulations such as gum, transdermal patch, nasal spray, oral inhaler, lozenge, Bupropion, Varenicline and newly emerged precision medicine
- Currently participating in other individual-based cessation program(s), such as psychological counseling, behavioral therapy etc.
- Currently under treatment of life-threatening medical conditions or critically ill
- Unable to make commitment of a consecutive 4-hour video viewing
- Plan to move out of the community in the next 3 month
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Shanghai Qingpu Patriotic Hygiene and Health Promotion Guidance Center
Shanghai, Shanghai Municipality, 201700, China
Related Publications (12)
GBD 2015 Risk Factors Collaborators. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016 Oct 8;388(10053):1659-1724. doi: 10.1016/S0140-6736(16)31679-8.
PMID: 27733284BACKGROUNDWang L, Shen Y, Jiang Y, Yang Y. [Investigation and analysis on current status of smoking cessation clinics in China]. Zhonghua Liu Xing Bing Xue Za Zhi. 2015 Sep;36(9):917-20. Chinese.
PMID: 26814853BACKGROUNDWang J, Xie L, Jiang Y, Li Q. Conclusions and impacts of U.S. Surgeon General' s Reports on smoking and tobacco use. Chinese Journal of Health Education 2012;28(7):591-593+601. DOI: 10.16168/j.cnki.issn.1002-9982.2012.07.019.
BACKGROUNDHuang X, Fu W, Zhang H, Li H, Li X, Yang Y, Wang F, Gao J, Zheng P, Fu H, Chapman S, Ding D. Why are male Chinese smokers unwilling to quit? A multicentre cross-sectional study on smoking rationalisation and intention to quit. BMJ Open. 2019 Feb 19;9(2):e025285. doi: 10.1136/bmjopen-2018-025285.
PMID: 30782929BACKGROUNDFotuhi O, Fong GT, Zanna MP, Borland R, Yong HH, Cummings KM. Patterns of cognitive dissonance-reducing beliefs among smokers: a longitudinal analysis from the International Tobacco Control (ITC) Four Country Survey. Tob Control. 2013 Jan;22(1):52-8. doi: 10.1136/tobaccocontrol-2011-050139. Epub 2012 Jan 3.
PMID: 22218426BACKGROUNDHuang X, Fu W, Zhang H, Li H, Li X, Yang Y, Wang F, Gao J, Zheng P, Fu H, Ding D, Chapman S. Development and validation of a smoking rationalization scale for male smokers in China. J Health Psychol. 2020 Mar;25(4):472-489. doi: 10.1177/1359105317720276. Epub 2017 Jul 20.
PMID: 28810494BACKGROUNDChen S, Gong E, Kazi DS, Gates AB, Bai R, Fu H, Peng W, De La Cruz G, Chen L, Liu X, Su Q, Girerd N, Karaye KM, Alhabib KF, Yan LL, Schwalm JD. Using Mobile Health Intervention to Improve Secondary Prevention of Coronary Heart Diseases in China: Mixed-Methods Feasibility Study. JMIR Mhealth Uhealth. 2018 Jan 25;6(1):e9. doi: 10.2196/mhealth.7849.
PMID: 29371178BACKGROUNDGong E, Gu W, Luo E, Tan L, Donovan J, Sun C, Yang Y, Zang L, Bao P, Yan LL. Development and Local Contextualization of Mobile Health Messages for Enhancing Disease Management Among Community-Dwelling Stroke Patients in Rural China: Multimethod Study. JMIR Mhealth Uhealth. 2019 Dec 17;7(12):e15758. doi: 10.2196/15758.
PMID: 31845901BACKGROUNDGong E, Sun L, Long Q, Xu H, Gu W, Bettger JP, Tan J, Ma J, Jafar TH, Oldenburg B, Yan LL. The Implementation of a Primary Care-Based Integrated Mobile Health Intervention for Stroke Management in Rural China: Mixed-Methods Process Evaluation. Front Public Health. 2021 Nov 17;9:774907. doi: 10.3389/fpubh.2021.774907. eCollection 2021.
PMID: 34869187BACKGROUNDNi Z, Liu C, Wu B, Yang Q, Douglas C, Shaw RJ. An mHealth intervention to improve medication adherence among patients with coronary heart disease in China: Development of an intervention. Int J Nurs Sci. 2018 Sep 8;5(4):322-330. doi: 10.1016/j.ijnss.2018.09.003. eCollection 2018 Oct 10.
PMID: 31406843BACKGROUNDYan LL, Gong E, Gu W, Turner EL, Gallis JA, Zhou Y, Li Z, McCormack KE, Xu LQ, Bettger JP, Tang S, Wang Y, Oldenburg B. Effectiveness of a primary care-based integrated mobile health intervention for stroke management in rural China (SINEMA): A cluster-randomized controlled trial. PLoS Med. 2021 Apr 28;18(4):e1003582. doi: 10.1371/journal.pmed.1003582. eCollection 2021 Apr.
PMID: 33909607BACKGROUNDTian M, Ajay VS, Dunzhu D, Hameed SS, Li X, Liu Z, Li C, Chen H, Cho K, Li R, Zhao X, Jindal D, Rawal I, Ali MK, Peterson ED, Ji J, Amarchand R, Krishnan A, Tandon N, Xu LQ, Wu Y, Prabhakaran D, Yan LL. A Cluster-Randomized, Controlled Trial of a Simplified Multifaceted Management Program for Individuals at High Cardiovascular Risk (SimCard Trial) in Rural Tibet, China, and Haryana, India. Circulation. 2015 Sep 1;132(9):815-24. doi: 10.1161/CIRCULATIONAHA.115.015373. Epub 2015 Jul 17.
PMID: 26187183BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 15, 2022
First Posted
August 19, 2022
Study Start
March 13, 2023
Primary Completion
May 31, 2023
Study Completion
June 30, 2023
Last Updated
February 28, 2024
Record last verified: 2024-02
Data Sharing
- IPD Sharing
- Will not share
The investigators will not share the individual participant data. But de-identified data is available upon request.